Biotech’s ‘distracted boyfriend’ is $3 billion richer. His fellow investors are still waiting for their share

Vivek Ramaswamy, the hedge fund manager turned biotech entrepreneur, was so confident he could make money from pharma drug castoffs, he named his new venture Roivant Sciences — the “Roi”